The transcriptom of inactivated human esophageal cancer cells by means of CRISPR/Cas9 technology
The transcriptomes were performed with PLCE1 inactivated human esophageal cancer cells by means of CRISPR/Cas9 technology, as well as the un-engineered control cells. Three independent samples of each type of cells were used for total RNA extraction with Qiagen RNeasy kit. Total RNA samples were sequenced via commercial service at BGI in China.